Skip to main content
Top
Published in: Journal of Nephrology 4/2020

01-08-2020 | Original Article

Assessment of increased glomerular permeability associated with recurrent focal segmental glomerulosclerosis using an in vitro model of the glomerular filtration barrier

Authors: Min Li, Carlo Maria Alfieri, William Morello, Francesco Cellesi, Silvia Armelloni, Deborah Mattinzoli, Giovanni Montini, Piergiorgio Messa

Published in: Journal of Nephrology | Issue 4/2020

Login to get access

Abstract

The presence of circulating permeability factors (cPFs) has been hypothesized to be associated with recurrence of focal segmental glomerulosclerosis (rFSGS) in renal allografts. The available methods to detect cPFs are complex, not easily repeatable and inappropriate to represent the anatomical characteristics of the three-layer glomerular filtration barrier (GFB). Here we describe a novel method which measures the permeability to bovine serum albumin (BSA) through a three-layer device (3LD). The 3 layers comprise: (1) conditionally immortalized human podocytes (HCiPodo), (2) collagen type IV coated porous membrane and (3) human glomerular endothelial cells (HCiGEnC). Using this method, we found that sera from all rFSGS patients increased albumin permeability, while sera from non recurrent (nrFSGS) and genetic (gFSGS) forms of FSGS did not. The mechanisms underlying the increase of albumin permeability are probably due to endothelial cell damage as an initial event, which was demonstrated by the decrease of Platelet endothelial cell adhesion molecule (PECAM-1 or CD31), while the podocytes’ expressions of synaptopodin and podocin were normal. Furthermore, we also found that the plasmapheretic treatment (PPT) eliminated the effect of increasing BSA permeability in sera from rFSGS patients. These preliminary data suggest that our in vitro GFB model could not only be useful in predicting the recurrence of FSGS after renal transplantation (RTx), but also be a valuable in vitro model to study podocyte and endothelial cell biology.
Appendix
Available only for authorised users
Literature
1.
go back to reference Chun MJ, Korbet SM, Schwartz MM et al (2004) Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants. J Am Soc Nephrol 15:2169–2177CrossRef Chun MJ, Korbet SM, Schwartz MM et al (2004) Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants. J Am Soc Nephrol 15:2169–2177CrossRef
2.
go back to reference Beaudreuil S, Lorenzo HK, Elias M et al (2017) Optimal management of primary focal segmental glomerulosclerosis in adults. Int J Nephrol Renovasc Dis 10:97–107CrossRef Beaudreuil S, Lorenzo HK, Elias M et al (2017) Optimal management of primary focal segmental glomerulosclerosis in adults. Int J Nephrol Renovasc Dis 10:97–107CrossRef
3.
go back to reference Maas RJ, Deegens JK, Wetzels JF (2014) Permeability factors in idiopathic nephrotic syndrome: historical perspectives and lessons for the future. Nephrol Dial Transpl 29(12):2207–2216CrossRef Maas RJ, Deegens JK, Wetzels JF (2014) Permeability factors in idiopathic nephrotic syndrome: historical perspectives and lessons for the future. Nephrol Dial Transpl 29(12):2207–2216CrossRef
4.
go back to reference Senggutuvan P, Cameron JS, Hartley RB et al (1990) Recurrence of focal segmental glomerulosclerosis in transplanted kidneys: analysis of incidence and risk factors in 59 allografts. Pediatr Nephrol 4:21–28CrossRef Senggutuvan P, Cameron JS, Hartley RB et al (1990) Recurrence of focal segmental glomerulosclerosis in transplanted kidneys: analysis of incidence and risk factors in 59 allografts. Pediatr Nephrol 4:21–28CrossRef
5.
go back to reference Savin VJ, Sharma R, Sharma M et al (1996) Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 334:878–883CrossRef Savin VJ, Sharma R, Sharma M et al (1996) Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med 334:878–883CrossRef
6.
go back to reference Dantal J, Bigot E, Bogers W et al (1994) Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome. N Engl J Med 330:7–14CrossRef Dantal J, Bigot E, Bogers W et al (1994) Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome. N Engl J Med 330:7–14CrossRef
7.
go back to reference Ingulli E, Tejani A (1991) Incidence, treatment, and outcome of recurrent focal segmental glomerulosclerosis posttransplantation in 42 allografts in children–a single-center experience. Transplantation 51:401–405CrossRef Ingulli E, Tejani A (1991) Incidence, treatment, and outcome of recurrent focal segmental glomerulosclerosis posttransplantation in 42 allografts in children–a single-center experience. Transplantation 51:401–405CrossRef
8.
go back to reference Artero M, Biava C, Amend W et al (1992) Recurrent focal glomerulosclerosis: natural history and response to therapy. Am J Med 92:375–383CrossRef Artero M, Biava C, Amend W et al (1992) Recurrent focal glomerulosclerosis: natural history and response to therapy. Am J Med 92:375–383CrossRef
9.
go back to reference Artero ML, Sharma R, Savin VJ et al (1994) Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis. Am J Kidney Dis 23:574–581CrossRef Artero ML, Sharma R, Savin VJ et al (1994) Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis. Am J Kidney Dis 23:574–581CrossRef
10.
go back to reference Dall’Amico R, Ghiggeri G, Carraro M et al (1999) Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in children. Am J Kidney Dis 34:1048–1055CrossRef Dall’Amico R, Ghiggeri G, Carraro M et al (1999) Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in children. Am J Kidney Dis 34:1048–1055CrossRef
11.
go back to reference Rea R, Smith C, Sandhu K et al (2001) Successful transplant of a kidney with focal segmental glomerulosclerosis. Nephrol Dial Transpl 16:416–417CrossRef Rea R, Smith C, Sandhu K et al (2001) Successful transplant of a kidney with focal segmental glomerulosclerosis. Nephrol Dial Transpl 16:416–417CrossRef
12.
go back to reference Kemper MJ, Wolf G, Muller-Wiefel DE (2001) Transmission of glomerular permeability factor from a mother to her child. N Engl J Med 344:386–387CrossRef Kemper MJ, Wolf G, Muller-Wiefel DE (2001) Transmission of glomerular permeability factor from a mother to her child. N Engl J Med 344:386–387CrossRef
13.
go back to reference Savin VJ, Sharma R, Lovell HB et al (1992) Measurement of albumin reflection coefficient with isolated rat glomeruli. J Am Soc Nephrol 3:1260–1269PubMed Savin VJ, Sharma R, Lovell HB et al (1992) Measurement of albumin reflection coefficient with isolated rat glomeruli. J Am Soc Nephrol 3:1260–1269PubMed
14.
go back to reference Pegoraro AA, Singh AK, Arruda JAL et al (2000) A simple method to detect an albimin permeabilità factor in the idiopathic nephrotic syndrome. Kidney Int 58:1342–1345CrossRef Pegoraro AA, Singh AK, Arruda JAL et al (2000) A simple method to detect an albimin permeabilità factor in the idiopathic nephrotic syndrome. Kidney Int 58:1342–1345CrossRef
15.
go back to reference Kachurina N, Chung CF, Benderoff E et al (2016) Novel unbiased assay for circulating podocyte-toxic factors associated with recurrent focal segmental glomerulosclerosis. Am J Physiol Renal Physiol 310:F1148–F1156CrossRef Kachurina N, Chung CF, Benderoff E et al (2016) Novel unbiased assay for circulating podocyte-toxic factors associated with recurrent focal segmental glomerulosclerosis. Am J Physiol Renal Physiol 310:F1148–F1156CrossRef
16.
go back to reference Srivastava P, Solanki AK, Arif E et al (2019) Development of a novel cell-based assay to diagnose recurrent focal segmental glomerulosclerosis patients. Kidney Int 95:708–716CrossRef Srivastava P, Solanki AK, Arif E et al (2019) Development of a novel cell-based assay to diagnose recurrent focal segmental glomerulosclerosis patients. Kidney Int 95:708–716CrossRef
17.
go back to reference Satchell SC, Tasman CT, Singh A et al (2006) Conditionally immortalized human glomerular endothelial cells expressing fenestrations in response to VEGF. Kidney Int 69:1633–1640CrossRef Satchell SC, Tasman CT, Singh A et al (2006) Conditionally immortalized human glomerular endothelial cells expressing fenestrations in response to VEGF. Kidney Int 69:1633–1640CrossRef
18.
go back to reference Saleem MA, O’Hare MJ, Reiser J et al (2002) A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J Am Soc Nephrol 13:630–638PubMed Saleem MA, O’Hare MJ, Reiser J et al (2002) A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J Am Soc Nephrol 13:630–638PubMed
19.
go back to reference Li M, Corbelli AS, Watanabe S et al (2016) Three-dimensional podocyte-endothelial cell co-cultures: assembly, validation, and application to drug testing and intercellular signaling studies. Eur J Pharm 86:1–12CrossRef Li M, Corbelli AS, Watanabe S et al (2016) Three-dimensional podocyte-endothelial cell co-cultures: assembly, validation, and application to drug testing and intercellular signaling studies. Eur J Pharm 86:1–12CrossRef
20.
go back to reference Bertani T, Poggi A, Pozzoni R et al (1982) Adriamycin-induced nephrotic syndrome in rats: sequence of pathologic events. Lab Invest 46:16–23PubMed Bertani T, Poggi A, Pozzoni R et al (1982) Adriamycin-induced nephrotic syndrome in rats: sequence of pathologic events. Lab Invest 46:16–23PubMed
21.
go back to reference Okuda S, Oh Y, Tsuruda H et al (1986) Adriamycin-induced nephropathy as a model of chronic progressive glomerular disease. Kidney Int 29:502–510CrossRef Okuda S, Oh Y, Tsuruda H et al (1986) Adriamycin-induced nephropathy as a model of chronic progressive glomerular disease. Kidney Int 29:502–510CrossRef
22.
go back to reference Belingheri M, Moroni G, Messa P (2018) Available and incoming therapies for idiopathic focal and segmental glomerulosclerosis in adults. J Nephrol 31:37–45CrossRef Belingheri M, Moroni G, Messa P (2018) Available and incoming therapies for idiopathic focal and segmental glomerulosclerosis in adults. J Nephrol 31:37–45CrossRef
23.
go back to reference Wei C, Möller CC, Altintas MM et al (2008) Modification of kidney barrier function by the urokinase receptor. Nat Med 14(1):55–63CrossRef Wei C, Möller CC, Altintas MM et al (2008) Modification of kidney barrier function by the urokinase receptor. Nat Med 14(1):55–63CrossRef
24.
go back to reference Savin VJ, Sharma M, Zhou J, Gennochi D, Fields T, Sharma R, McCarthy ET, Srivastava T, Domen J, Tormo A, Gauchat JF (2015) Renal and hematological effects of CLCF-1, a B-cell-stimulating cytokine of the IL-6 family. J Immunol Res 2015:714964CrossRef Savin VJ, Sharma M, Zhou J, Gennochi D, Fields T, Sharma R, McCarthy ET, Srivastava T, Domen J, Tormo A, Gauchat JF (2015) Renal and hematological effects of CLCF-1, a B-cell-stimulating cytokine of the IL-6 family. J Immunol Res 2015:714964CrossRef
25.
go back to reference Delville M, Sigdel TK, Wei C et al (2014) A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation. Sci Transl Med 6(256):256ra136CrossRef Delville M, Sigdel TK, Wei C et al (2014) A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation. Sci Transl Med 6(256):256ra136CrossRef
26.
go back to reference Privratsky JR, Paddock CM, Florey O et al (2011) Relative contribution of PECAM-1 adhesion and signaling to the maintenance of vascular integrity. JCS 124:1477–1485CrossRef Privratsky JR, Paddock CM, Florey O et al (2011) Relative contribution of PECAM-1 adhesion and signaling to the maintenance of vascular integrity. JCS 124:1477–1485CrossRef
27.
go back to reference Ferrero E, Ferrero ME, Pardi R et al (1995) The platelet endothelial cell adhesion molecule-1 (PECAM1) contributes to endothelia barrier function. FEBS Lett 374:323–326CrossRef Ferrero E, Ferrero ME, Pardi R et al (1995) The platelet endothelial cell adhesion molecule-1 (PECAM1) contributes to endothelia barrier function. FEBS Lett 374:323–326CrossRef
Metadata
Title
Assessment of increased glomerular permeability associated with recurrent focal segmental glomerulosclerosis using an in vitro model of the glomerular filtration barrier
Authors
Min Li
Carlo Maria Alfieri
William Morello
Francesco Cellesi
Silvia Armelloni
Deborah Mattinzoli
Giovanni Montini
Piergiorgio Messa
Publication date
01-08-2020
Publisher
Springer International Publishing
Published in
Journal of Nephrology / Issue 4/2020
Print ISSN: 1121-8428
Electronic ISSN: 1724-6059
DOI
https://doi.org/10.1007/s40620-019-00683-2

Other articles of this Issue 4/2020

Journal of Nephrology 4/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.